Evidence map›Paper›PMID 33966944›Full record

ArticleZeitschrift fur medizinische Physik2022

Feasibility and clinical usefulness of modelling glioblastoma migration in adjuvant radiotherapy.

Sven Knobe, Yvonne Dzierma, Michael Wenske, Christian Berdel, Jochen Fleckenstein, Patrick Melchior, Jan Palm, Frank G Nuesken, Alexander Hunt, Christian Engwer and 4 more

Abstract read
In one paragraph

Article in Zeitschrift fur medizinische Physik, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Sven KnobeDepartment of Radiotherapy and Radiation Oncology, Saarland University Medical Center, Homburg/Saar, Germany. Electronic address: sven.knobe@uks.eu.
Yvonne DziermaDepartment of Radiotherapy and Radiation Oncology, Saarland University Medical Center, Homburg/Saar, Germany.
Michael WenskeInstitute for Analysis and Numerics, University of Muenster, Muenster, Germany.
Christian BerdelDepartment of Radiotherapy and Radiation Oncology, Saarland University Medical Center, Homburg/Saar, Germany.
Jochen FleckensteinDepartment of Radiotherapy and Radiation Oncology, Saarland University Medical Center, Homburg/Saar, Germany.
Patrick MelchiorDepartment of Radiotherapy and Radiation Oncology, Saarland University Medical Center, Homburg/Saar, Germany.
Jan PalmDepartment of Radiotherapy and Radiation Oncology, Saarland University Medical Center, Homburg/Saar, Germany.
Frank G NueskenDepartment of Radiotherapy and Radiation Oncology, Saarland University Medical Center, Homburg/Saar, Germany.
Alexander HuntCarl Zeiss Automated Inspection GmbH, Öhringen, Germany.
Christian EngwerInstitute for Analysis and Numerics, University of Muenster, Muenster, Germany.
Christina SurulescuFelix Klein Centre for Mathematics, University of Kaiserslautern, Kaiserslautern, Germany.
Umut YilmazDepartment of Diagnostic and Interventional Radiology, Saarland University Medical Center, Homburg/Saar, Germany.
Wolfgang ReithDepartment of Diagnostic and Interventional Radiology, Saarland University Medical Center, Homburg/Saar, Germany.
Christian RübeDepartment of Radiotherapy and Radiation Oncology, Saarland University Medical Center, Homburg/Saar, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Glioblastoma (GBM) is one of the most common primary brain tumours in adults, with a dismal prognosis despite aggressive multimodality treatment by a combination of surgery and adjuvant radiochemotherapy. A detailed knowledge of the spreading of glioma cells in the brain might allow for more targeted escalated radiotherapy, aiming to reduce locoregional relapse. Recent years have seen the development of a large variety of mathematical modelling approaches to predict glioma migration. The aim of this study is hence to evaluate the clinical applicability of a detailed micro- and meso-scale mathematical model in radiotherapy. First and foremost, a clinical workflow is established, in which the tumour is automatically segmented as input data and then followed in time mathematically based on the diffusion tensor imaging data. The influence of several free model parameters is individually evaluated, then the full model is retrospectively validated for a collective of 3 GBM patients treated at our institution by varying the most important model parameters to achieve optimum agreement with the tumour development during follow-up. Agreement of the model predictions with the real tumour growth as defined by manual contouring based on the follow-up MRI images is analyzed using the dice coefficient. The tumour evolution over 103-212 days follow-up could be predicted by the model with a dice coefficient better than 60% for all three patients. In all cases, the final tumour volume was overestimated by the model by a factor between 1.05 and 1.47. To evaluate the quality of the agreement between the model predictions and the ground truth, we must keep in mind that our gold standard relies on a single observer's (CB) manually-delineated tumour contours. We therefore decided to add a short validation of the stability and reliability of these contours by an inter-observer analysis including three other experienced radiation oncologists from our department. In total, a dice coefficient between 63% and 89% is achieved between the four different observers. Compared with this value, the model predictions (62-66%) perform reasonably well, given the fact that these tumour volumes were created based on the pre-operative segmentation and DTI.

Indexed as

GlioblastomaGliomaAdultDiffusion Tensor ImagingFeasibility StudiesHumansObserver VariationRadiotherapy, AdjuvantReproducibility of ResultsRetrospective StudiesBio-mathematical modellingGlioblastoma growth and migrationGlioblastoma radiotherapyInter observer analysisTumour segmentation

Identifiers

PMID33966944
PMCPMC9948823

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.